These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 21243406)
1. A proteomic investigation into adriamycin chemo-resistance of human leukemia K562 cells. Peng X; Gong F; Xie G; Zhao Y; Tang M; Yu L; Tong A Mol Cell Biochem; 2011 May; 351(1-2):233-41. PubMed ID: 21243406 [TBL] [Abstract][Full Text] [Related]
2. Involvement of annexin A1 in multidrug resistance of K562/ADR cells identified by the proteomic study. Zhu F; Wang Y; Zeng S; Fu X; Wang L; Cao J OMICS; 2009 Dec; 13(6):467-76. PubMed ID: 20001861 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of mitochondrial ATPase by hypermethylation mechanism in chronic myeloid leukemia is associated with multidrug resistance. Li RJ; Zhang GS; Chen YH; Zhu JF; Lu QJ; Gong FJ; Kuang WY Ann Oncol; 2010 Jul; 21(7):1506-1514. PubMed ID: 20038517 [TBL] [Abstract][Full Text] [Related]
4. Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression. Pan J; Miao D; Chen L Chem Biol Interact; 2018 May; 288():32-37. PubMed ID: 29655913 [TBL] [Abstract][Full Text] [Related]
5. [Up-regulation of Stathmin and CrkL protein expressions in adriamycin-resistant leukemia cell line K562/A02]. Xu JP; Hu JD; Lin MH; Li J; Liu TB Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1383-7. PubMed ID: 22169288 [TBL] [Abstract][Full Text] [Related]
6. Proteomic-based identification of Apg-2 as a therapeutic target for chronic myeloid leukemia. Li Y; Chen X; Shi M; Wang H; Cao W; Wang X; Li C; Feng W Cell Signal; 2013 Dec; 25(12):2604-12. PubMed ID: 24012954 [TBL] [Abstract][Full Text] [Related]
7. Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair. Majsterek I; Sliwinski T; Poplawski T; Pytel D; Kowalski M; Slupianek A; Skorski T; Blasiak J Mutat Res; 2006 Jan; 603(1):74-82. PubMed ID: 16388976 [TBL] [Abstract][Full Text] [Related]
8. Identification of differentially expressed proteins in imatinib mesylate-resistant chronic myelogenous cells. Park J; Kim S; Oh JK; Kim JY; Yoon SS; Lee D; Kim Y J Biochem Mol Biol; 2005 Nov; 38(6):725-38. PubMed ID: 16336789 [TBL] [Abstract][Full Text] [Related]
9. [Development of a K562 multidrug-resistant cell line and study on proteins with altered expression]. Wang Y; Cao J; Zeng S Shi Yan Sheng Wu Xue Bao; 2003 Oct; 36(5):342-6. PubMed ID: 14724945 [TBL] [Abstract][Full Text] [Related]
10. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway. Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633 [TBL] [Abstract][Full Text] [Related]
11. CD44 enhances adriamycin resistance in chronic myelogenous leukaemia cells K562. Li J; Zhang Y; Cui Y; Jin H; Lin Z; Piao Y; Jin J Int J Lab Hematol; 2021 Oct; 43(5):983-989. PubMed ID: 33411349 [TBL] [Abstract][Full Text] [Related]
12. Identification of proteins responsible for the development of adriamycin resistance in human gastric cancer cells using comparative proteomics analysis. Yang YX; Hu HD; Zhang DZ; Ren H J Biochem Mol Biol; 2007 Nov; 40(6):853-60. PubMed ID: 18047778 [TBL] [Abstract][Full Text] [Related]
13. Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells. Shi YQ; Qu XJ; Liao YX; Xie CF; Cheng YN; Li S; Lou HX Eur J Pharmacol; 2008 Apr; 584(1):66-71. PubMed ID: 18304528 [TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of an imatinib-resistant K562 cell line highlights opposing roles of heat shock cognate 70 and heat shock 70 proteins in resistance. Pocaly M; Lagarde V; Etienne G; Dupouy M; Lapaillerie D; Claverol S; Vilain S; Bonneu M; Turcq B; Mahon FX; Pasquet JM Proteomics; 2008 Jun; 8(12):2394-406. PubMed ID: 18563733 [TBL] [Abstract][Full Text] [Related]
15. Comparative proteomic analysis of chronic myelogenous leukemia cells: inside the mechanism of imatinib resistance. Ferrari G; Pastorelli R; Buchi F; Spinelli E; Gozzini A; Bosi A; Santini V J Proteome Res; 2007 Jan; 6(1):367-75. PubMed ID: 17203980 [TBL] [Abstract][Full Text] [Related]
16. A comparative proteomic study of Homoharringtonine-induced apoptosis in leukemia K562 cells. Zhou X; Xu N; Li R; Xiao Y; Gao G; Lu Q; Ding L; Li L; Li Y; Du Q; Liu X Leuk Lymphoma; 2015 Jul; 56(7):2162-9. PubMed ID: 25330443 [TBL] [Abstract][Full Text] [Related]
17. FK506 reverses adriamycin resistance in a multidrug-resistant human leukemia cell line. Natazuka T Kobe J Med Sci; 1992 Dec; 38(6):347-63. PubMed ID: 1284834 [TBL] [Abstract][Full Text] [Related]
18. Characteristics of dasatinib- and imatinib-resistant chronic myelogenous leukemia cells. Okabe S; Tauchi T; Ohyashiki K Clin Cancer Res; 2008 Oct; 14(19):6181-6. PubMed ID: 18829496 [TBL] [Abstract][Full Text] [Related]
19. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells. Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065 [TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of docetaxel resistance in human nasopharyngeal carcinoma cells using the two-dimensional gel electrophoresis method. Peng X; Gong FM; Ren M; Ai P; Wu S; Tang J; Hu X Anticancer Drugs; 2016 Sep; 27(8):748-55. PubMed ID: 27333594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]